Skip to content

Good adherence seen in study of intermittent PrEP

Jean-Michel Molina speaking at AIDS 2014. Photo: International AIDS Society/Steve Forrest.

Overall PrEP effectiveness in iPrEx OLE study 50%, but 100% in those taking four or more doses a week

Robert Grant, iPrEx study principal researcher. ©IAS/Marcus Rose/Worker's Photos

European CDC cautious about PrEP

High levels of adherence to study medication among women who conceived during HIV PrEP study

PrEP users say it provides an 'extra layer of protection' and 'peace of mind'

Model shows potential for substantial long-term HIV risk for serodifferent couples, even with new prevention tools

Tenofovir HIV PrEP causes no long-term harm to kidneys

New US guidelines recommend PrEP

Daily dosing key to the efficacy of tenofovir-based HIV PrEP